UA84747U - Method for correcting metabolic disorders in patients with hodgkin lymphoma in setting of alcohol addiction - Google Patents
Method for correcting metabolic disorders in patients with hodgkin lymphoma in setting of alcohol addictionInfo
- Publication number
- UA84747U UA84747U UAU201306901U UAU201306901U UA84747U UA 84747 U UA84747 U UA 84747U UA U201306901 U UAU201306901 U UA U201306901U UA U201306901 U UAU201306901 U UA U201306901U UA 84747 U UA84747 U UA 84747U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- setting
- hodgkin lymphoma
- metabolic disorders
- days
- Prior art date
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 2
- 208000017604 Hodgkin disease Diseases 0.000 title abstract 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 title abstract 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 title abstract 2
- 208000030159 metabolic disease Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 abstract 1
- RVEWUBJVAHOGKA-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;2-aminopentanedioic acid Chemical compound OC(=O)C(N)CCC(O)=O.OC(=O)C(N)CCCN=C(N)N RVEWUBJVAHOGKA-UHFFFAOYSA-N 0.000 abstract 1
- 108010006654 Bleomycin Proteins 0.000 abstract 1
- 229960001561 bleomycin Drugs 0.000 abstract 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 abstract 1
- 229960004679 doxorubicin Drugs 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000000644 isotonic solution Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 230000009469 supplementation Effects 0.000 abstract 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 abstract 1
- 229960003048 vinblastine Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for correcting the metabolic disorders in the patients with Hodgkin lymphoma in the setting of alcohol addiction comprises the supplementation of ABDV regimen (Doxorubicin 25 mg/mi/v on Days 1 and 14, Bleomycin 10 mg/mi/v on Days 1 and 14, Vinblastin 6 mg/mi/v on Days 1 and 14, Dacarbasin 375 mg/mi/v on Days 1 and 14 with 14-day interval between the cycles) with Glutargin administered as 4 % solution in isotonic solution of sodium chloride (200 mL) in a volume of 30-40 mL as intravenous infusion every other day (2, 4, 6, 8, 9, 11, 13) and in tablets (two tablets 0.5 thrice a day).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201306901U UA84747U (en) | 2013-06-01 | 2013-06-01 | Method for correcting metabolic disorders in patients with hodgkin lymphoma in setting of alcohol addiction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201306901U UA84747U (en) | 2013-06-01 | 2013-06-01 | Method for correcting metabolic disorders in patients with hodgkin lymphoma in setting of alcohol addiction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA84747U true UA84747U (en) | 2013-10-25 |
Family
ID=52284149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201306901U UA84747U (en) | 2013-06-01 | 2013-06-01 | Method for correcting metabolic disorders in patients with hodgkin lymphoma in setting of alcohol addiction |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA84747U (en) |
-
2013
- 2013-06-01 UA UAU201306901U patent/UA84747U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ738525A (en) | Cot modulators and methods of use thereof | |
| MX345747B (en) | Wearable automatic injection device. | |
| NZ738538A (en) | 6-amino-quinoline-3-carbonitrils as cot modulators | |
| AR096184A1 (en) | ANTIBODY COMBINATION THERAPY FOR CD20 AFUCOSILATED WITH AN ANTIBODY CONJUGATE FOR CD22-DRUG | |
| MX337464B (en) | Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents. | |
| UA84747U (en) | Method for correcting metabolic disorders in patients with hodgkin lymphoma in setting of alcohol addiction | |
| WO2014184666A3 (en) | Cell therapy for myelodysplastic syndromes | |
| CA2924615C (en) | Tooth implant | |
| RU2012123182A (en) | METHOD FOR CORRECTION OF MENTAL STATE OF PATIENTS AND ANTIOXIDANT STATUS IN ORGANIC DISORDER OF PERSONALITY | |
| UA81924U (en) | Method for treating patients with hiv/aids-associated chemoresistant tuberculosis | |
| UA89692U (en) | Method for treatment of patients with chemoresistant destructive pulmonary tuberculosis complicated with endobronchial pathology | |
| UA71921U (en) | Method for treating toxic neuroretinopathy of alcohol etiology | |
| UA89638U (en) | Method for treating aged patients with syndrome of vascular cognitive impairment | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| RU2012123184A (en) | METHOD FOR CONTROLLED REDUCTION OF THE AGGREGATION ACTIVITY OF THROMBOCYTES BY MEXIDOL IN THE EXPERIMENT | |
| UA87115U (en) | Method for treating acute ischemic stroke | |
| UA87633U (en) | Method for modeling liver cirrhosis with syndrome of portal hypertension | |
| UA87116U (en) | Method for treating acute ischemic stroke | |
| UA104128U (en) | Method for treatment of acute ischemic stroke | |
| UA89109U (en) | Method for treating antiphospholipid syndrome | |
| UA55973U (en) | Method for correcting metabolic shifts in recurrent non-diabetic ketonemia in setting of nervous-arthritic anomaly of constitution in children | |
| UA89104U (en) | Method for treating antiphospholipid syndrome | |
| UA75754U (en) | method for treating patients with nonproliferative diabetic retinopathy | |
| Shindorf | Aprepitant/cisplatin/ifosfamide | |
| UA89128U (en) | Method for treating antiphospholipid syndrome |